PD-L1 Gene Amplification
3 clinical trials · Condition
◉ Watch PD-L1 Gene Amplification
| Record | Firm | Date |
|---|---|---|
| Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer (NCT05859477) | Kidney Cancer Research Bureau | 2022-06-05 |
Track PD-L1 Gene Amplification automatically
Every clearance here is in the API, with alerts when new ones post.